Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Donner

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Surgery|December 2, 2008
Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancersDaniel T Ruan, Robert S Warren, Jacob Moalem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2013
Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803Robert S Warren, Chloe E Atreya, Donna Niedzwiecki, et al.
Oncogene|April 2, 2013
Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitorsG S Ducker, C E Atreya, J P Simko, et al.
The Journal of Biological Chemistry|March 16, 2011
CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)Ranjana Mitra, Zhijun Guo, Monica Milani, et al.
Endocrine-Related Cancer|November 7, 2008
Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumorsYu-Cheng Wang, Emerick Gallego-Arteche, Gioia Iezza, et al.
Molecular Cancer Therapeutics|September 27, 2018
A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant TumorsChester E Chamberlain, Michael S German, Katherine Yang, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Surgery|December 2, 2008
Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancersDaniel T Ruan, Robert S Warren, Jacob Moalem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2013
Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803Robert S Warren, Chloe E Atreya, Donna Niedzwiecki, et al.
Oncogene|April 2, 2013
Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitorsG S Ducker, C E Atreya, J P Simko, et al.
The Journal of Biological Chemistry|March 16, 2011
CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)Ranjana Mitra, Zhijun Guo, Monica Milani, et al.
Endocrine-Related Cancer|November 7, 2008
Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumorsYu-Cheng Wang, Emerick Gallego-Arteche, Gioia Iezza, et al.
Molecular Cancer Therapeutics|September 27, 2018
A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant TumorsChester E Chamberlain, Michael S German, Katherine Yang, et al.
Pageof 13